摘要 |
The invention provides an amorphous form of Dorzolamide hydrochloride, processes for the preparation of amorphous Dorzolamide hydrochloride, processes for making Form II from amorphous Dorzolamide HCl5 a crystalline form of Dorzolamide hydrochloride, Form IV, process for making Form IV, and pharmaceutical compositions of amorphous Dorzolamide hydrochloride, Dorzolamide hydrochloride Form II and Dorzolamide hydrochloride Form IV. |
申请人 |
TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG;TEVA PHARMACEUTICALS USA, INC.;ARONHIME, JUDITH;NEMETHNE RACZ, CSILLA;KOVACSNE-MEZEI, ADRIENNE;SZABO, CSABA;KOVACS, LASZLO;GYURICZA, LORANT |
发明人 |
ARONHIME, JUDITH;NEMETHNE RACZ, CSILLA;KOVACSNE-MEZEI, ADRIENNE;SZABO, CSABA;KOVACS, LASZLO;GYURICZA, LORANT |